GSK-217744/070 (DTPa-HBV-IPV-070)

An open clinical study to assess the immunogenicity and safety of GSK Biologicals' DTPa-HBV-IPV vaccine mixed in one syringe with Hib vaccine, as a primary vaccination course to pre-term infants (<37 weeks) at 2, 4 and 6 months of age in comparison with infants born after normal gestation period
Combined Diphtheria, Tetanus, Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), Inactivated Polio Vaccine
217744/070 (DTPa-HBV-IPV-070)
Acellular pertussis; Diphtheria; Hepatitis B; Poliomyelitis; Tetanus
Phase 3
An annotated case report form is not available for this study. A blank case report form will be provided.
June 2015